Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$810M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$745M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$671M |
| 4 |
Boeing
BA
|
+$390M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$784M |
| 2 |
NVIDIA
NVDA
|
+$532M |
| 3 |
Apple
AAPL
|
+$491M |
| 4 |
Amazon
AMZN
|
+$438M |
| 5 |
Newmont
NEM
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Financials | 11.26% |
| 3 | Healthcare | 8.31% |
| 4 | Industrials | 8.25% |
| 5 | Consumer Discretionary | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Centrus Energy
LEU
$3.48B
| $716K | ﹤0.01% |
10,755
-639
| -6% | -$49.9K |
|
|
SLRN
3327
DELISTED
ACELYRIN
SLRN
| $716K | ﹤0.01% |
228,098
-8,564
| -4% | -$41.5K |
|
3328
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
| $715K | ﹤0.01% |
26,389
-18,656
| -41% | -$525K |
|
3329
Pagaya Technologies
PGY
$1.61B
| $714K | ﹤0.01% |
76,818
-2,146
| -3% | -$22.7K |
|
3330
Invesco S&P 500 Momentum ETF
SPMO
$20.8B
| $712K | ﹤0.01% |
7,499
+1,793
| +31% | +$170K |
|
3331
Sprott Physical Gold
PHYS
$14.6B
| $712K | ﹤0.01% |
35,371
-1,740
| -5% | -$35.8K |
|
3332
Quantum Computing Inc
QUBT
$1.83B
| $712K | ﹤0.01% |
+43,034
| New | +$236K |
|
3333
Kyverna Therapeutics
KYTX
$444M
| $712K | ﹤0.01% |
190,383
+67,606
| +55% | +$324K |
|
3334
Xeris Biopharma Holdings
XERS
$1.39B
| $712K | ﹤0.01% |
209,923
-7,166
| -3% | -$23.1K |
|
3335
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$332M
| $710K | ﹤0.01% |
40,018
-1,416
| -3% | -$24.3K |
|
|
LAR
3336
Lithium Argentina AG
LAR
$985M
| $708K | ﹤0.01% |
270,415
-17,634
| -6% | -$57.4K |
|
3337
PetMed Express
PETS
$41.7M
| $706K | ﹤0.01% |
146,373
| – | – |
|
3338
Aura Biosciences
AURA
$725M
| $704K | ﹤0.01% |
85,586
-2,006
| -2% | -$18.9K |
|
3339
Entrada Therapeutics
TRDA
$264M
| $702K | ﹤0.01% |
40,624
+2,517
| +7% | +$45.6K |
|
3340
Fortis
FTS
$29B
| $701K | ﹤0.01% |
12,484
-8,853
| -41% | -$387K |
|
3341
1st Source
SRCE
$2.16B
| $692K | ﹤0.01% |
11,855
+3,165
| +36% | +$196K |
|
3342
India Internet & Ecommerce ETF
INQQ
$45.3M
| $689K | ﹤0.01% |
+42,578
| New | +$694K |
|
3343
Global X Lithium & Battery Tech ETF
LIT
$1.51B
| $684K | ﹤0.01% |
16,785
-255
| -1% | -$11.2K |
|
|
HONE
3344
DELISTED
HarborOne Bancorp
HONE
| $683K | ﹤0.01% |
57,729
| – | – |
|
|
SAGE
3345
DELISTED
Sage Therapeutics
SAGE
| $682K | ﹤0.01% |
125,630
-88,350
| -41% | -$540K |
|
3346
NovoCure
NVCR
$1.73B
| $682K | ﹤0.01% |
22,883
+10,007
| +78% | +$212K |
|
|
GRAL
3347
GRAIL Inc
GRAL
$2.94B
| $681K | ﹤0.01% |
+38,142
| New | +$620K |
|
|
ML
3348
DELISTED
MoneyLion Inc.
ML
| $679K | ﹤0.01% |
7,897
-10,518
| -57% | -$709K |
|
3349
Corsair Gaming
CRSR
$1.13B
| $678K | ﹤0.01% |
102,636
-41,798
| -29% | -$290K |
|
3350
Hudbay
HBM
$10.1B
| $676K | ﹤0.01% |
83,498
+863
| +1% | +$7.74K |
|
Similar funds
Ameriprise's Q4 2024 Portfolio in Review
As of Q4 2024, Ameriprise held 4,210 positions worth $390B, down 0.05% from $390B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q4 2024 filing shows 290 new, 1,777 increased, 1,865 reduced and 140 closed positions. Its largest new stake was Primo Brands: 2,607,261 shares worth $80.2M. The largest sale was Elevance Health, an estimated $784M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2024 buy was Primo Brands: 2,607,261 shares worth $80.2M.
- Ameriprise added most to iShares Core US Aggregate Bond ETF in Q4 2024, an estimated $810M increase.
- Ameriprise's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $784M.
- Ameriprise fully exited Primo Water Corporation in Q4 2024, selling an estimated $62.3M.
- Ameriprise's ten largest holdings make up 21% of its $390B portfolio in Q4 2024.
- Ameriprise opened 290 new positions and closed 140 in Q4 2024.
- Ameriprise's portfolio value fell 0.05% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.